Hem/Onc Board Review (@hemoncq) 's Twitter Profile
Hem/Onc Board Review

@hemoncq

Hematology/oncology board review style questions. By @ahmadalhader and @DrM_AbuZaid

ID: 1315371414766211077

calendar_today11-10-2020 19:19:50

741 Tweet

1,1K Followers

493 Following

Ivy Riano, M.D. (@ivylorena_md) 's Twitter Profile Photo

I am pleased to share this article written with my colleague Fawzi Abu Rous, MD, in which we share our experiences as IMG during the COVID-19 pandemic cc Aakash Desai, MD, MPH, FASCO tandfonline.com/doi/full/10.10…

I am pleased to share this article written with my colleague <a href="/FawziAbuRous/">Fawzi Abu Rous, MD</a>, in which we share our experiences as IMG during the COVID-19 pandemic

cc <a href="/ADesaiMD/">Aakash Desai, MD, MPH, FASCO</a> 

tandfonline.com/doi/full/10.10…
TwoOncDocs (@twooncdocs) 's Twitter Profile Photo

Today we cover another #thalassemia, Alpha Thalassemia! 🩸 For a patient with a Hb of 11, MCV of 67, ferritin of 60, and a NORMAL Hb electrophoresis, what is the most likely diagnosis? #hematology #hemonc #meded

Hem/Onc Board Review (@hemoncq) 's Twitter Profile Photo

71 year old woman with stage 4 ALK rearranged lung adenocarcinoma on Lorlatinib. Other than mild edema in lower extremities, she is tolerating treatment well. Scans have shown evidence of partial response. Which of the following labs are recommended routinely?

Samer Al Hadidi, MD,MS,FACP (@hadidisamer) 's Twitter Profile Photo

Help us spread the word&complete a survey to understand adoption of ICC/WHO myeloid&lymphoid neoplasm classification in 🇺🇸 ➡️can complete on your phone ✅project led by a fellow (👏) ➡️ redcap.ccf.org/redcap/surveys… #OncTwitter #HemeTwitter #AcademicTwitter #PathTwitter #hemepath

Help us spread the word&amp;complete a survey to understand adoption of ICC/WHO myeloid&amp;lymphoid neoplasm classification in 🇺🇸
➡️can complete on your phone 
✅project led by a fellow (👏) 
➡️ redcap.ccf.org/redcap/surveys…
#OncTwitter #HemeTwitter #AcademicTwitter #PathTwitter #hemepath
Eric K. Singhi, MD (@lungoncdoc) 's Twitter Profile Photo

☣️ Rare but life-threatening irAEs can have a lasting impact on our patients. #OncTwitter, how do you strike a balance between effectively obtaining IO consent & communicating potential serious irAEs to patients without undue distress? H. Jack West, MD, FASCO Jarushka Naidoo Jill Feldman

☣️ Rare but life-threatening irAEs can have a lasting impact on our patients.  

#OncTwitter, how do you strike a balance between effectively obtaining IO consent &amp; communicating potential serious irAEs to patients without undue distress? <a href="/JackWestMD/">H. Jack West, MD, FASCO</a> <a href="/DrJNaidoo/">Jarushka Naidoo</a> <a href="/jillfeldman4/">Jill Feldman</a>
TwoOncDocs (@twooncdocs) 's Twitter Profile Photo

We are back this week with Tom Powles & Brian Rini, MD diving into metastatic RCC! We discuss risk stratification, their differing opinions around cytoreductive nephrectomy, 1L tx & sequencing, pearls regarding sarcomatoid, non-clear-cell RCC & tips for trainees Uromigos

We are back this week with <a href="/tompowles1/">Tom Powles</a> &amp; <a href="/brian_rini/">Brian Rini, MD</a> diving into metastatic RCC!

We discuss risk stratification, their differing opinions around cytoreductive nephrectomy, 1L tx &amp; sequencing, pearls regarding sarcomatoid, non-clear-cell RCC &amp; tips for trainees <a href="/Uromigos/">Uromigos</a>
Hem/Onc Board Review (@hemoncq) 's Twitter Profile Photo

Definitely! For the boards, you don’t necessarily need to know the studies or the actual evidence (for the most part). You need to know first line, second line tx, etc

Indiana University Hematology/Oncology Fellowship (@iuhemonc) 's Twitter Profile Photo

Our fellow Ahmed Bilal Khalid recently attended the ASCR/ASCO Methods in Clinical Cancer Research Workshop to continue developing a clinical trial with our excellent GU faculty. Way to go!

Indiana University Hematology/Oncology Fellowship (@iuhemonc) 's Twitter Profile Photo

Our fellow Noah Richardson attended the AACR Molecular Biology in Clinical Oncology workshop, focused on molecular biology, translational cancer research, career development, and grant writing for the aspiring physician-scientist. Congrats! IU Simon Comprehensive Cancer Center

Our fellow <a href="/Noah_Onc/">Noah Richardson</a> attended the AACR Molecular Biology in Clinical Oncology workshop, focused on molecular biology, translational cancer research, career development, and grant writing for the aspiring physician-scientist. Congrats!
<a href="/IUCancerCenter/">IU Simon Comprehensive Cancer Center</a>
TwoOncDocs (@twooncdocs) 's Twitter Profile Photo

This week’s episode we discussed our favorite heme/onc board review resources - books, Qbanks, podcasts ect 📕 🖥️ 🎙️ podcasts.apple.com/us/podcast/two…

This week’s episode we discussed our favorite heme/onc board review resources - books, Qbanks, podcasts ect 📕 🖥️ 🎙️ 

podcasts.apple.com/us/podcast/two…
TwoOncDocs (@twooncdocs) 's Twitter Profile Photo

Thank you all who joined Clinicals to Exams & guest appearance w/ baby Cary A few high-yield mnemonics: 🌟 ribociclib - “ribs” close to ❤️- Qtc; abemaciclib - “abs” - diarrhea 🌟 tumor marker half-life: Hcg -3 letters, 1-3d; AFP -alpha - 5 letters 5-7d Ready for #ASCO25 day 1!

Thank you all who joined Clinicals to Exams &amp; guest appearance w/ baby Cary

A few high-yield mnemonics:
🌟 ribociclib - “ribs” close to ❤️- Qtc; abemaciclib - “abs” - diarrhea
🌟 tumor marker half-life: Hcg -3 letters, 1-3d; AFP -alpha - 5 letters 5-7d 

Ready for #ASCO25 day 1!
Indiana University Hematology/Oncology Fellowship (@iuhemonc) 's Twitter Profile Photo

Congrats to chief fellow Noah Richardson for their Conquer Cancer, the ASCO Foundation Young Investigator Award investigating novel prostate cancer therapeutics and our brilliant faculty member Misty Dawn Shields Career Development Award in lung cancer. #ASCO2025 is off to a great start! IU Simon Comprehensive Cancer Center

Congrats to chief fellow <a href="/Noah_Onc/">Noah Richardson</a> for their <a href="/ConquerCancerFd/">Conquer Cancer, the ASCO Foundation</a> Young Investigator Award investigating novel prostate cancer therapeutics and our brilliant faculty member <a href="/drshieldsmd/">Misty Dawn Shields</a> Career Development Award in lung cancer. #ASCO2025 is off to a great start! <a href="/IUCancerCenter/">IU Simon Comprehensive Cancer Center</a>
Omar Abu Ghanimeh (@omarabughanimeh) 's Twitter Profile Photo

Proud to be an investigator in the head and neck cohort of SGN35-033. Our data was discussed today at ASCO, showing promising clinical efficacy of BV + Pembro in treatment -naive patients with metastatic HNSCC and CPS ≥1. meetings.asco.org/abstracts-pres… Nebraska Medicine UNMC Heme Onc

Proud to be an investigator in the head and neck cohort of SGN35-033. Our data was discussed today at <a href="/ASCO/">ASCO</a>, showing  promising clinical efficacy of BV + Pembro in treatment -naive patients with  metastatic HNSCC and CPS ≥1.

meetings.asco.org/abstracts-pres…

<a href="/NebraskaMed/">Nebraska Medicine</a> <a href="/UNMCHemeOnc/">UNMC Heme Onc</a>